Instrumental 发表于 2025-3-26 22:06:07
http://reply.papertrans.cn/47/4648/464703/464703_31.png大看台 发表于 2025-3-27 04:05:54
http://reply.papertrans.cn/47/4648/464703/464703_32.png直言不讳 发表于 2025-3-27 07:35:54
Etiology and Pathogenesis of Inflammatory Bowel Disease,ever, progress in IBD research has fostered development of new agents that target pivotal processes in disease pathogenesis .. This chapter addresses the etiology and pathogenesis of IBD, including the latest developments in animal models. It will serve as a basis for understanding current and future therapeutic development.羞辱 发表于 2025-3-27 11:11:51
http://reply.papertrans.cn/47/4648/464703/464703_34.pngOrnament 发表于 2025-3-27 13:50:21
http://reply.papertrans.cn/47/4648/464703/464703_35.png清真寺 发表于 2025-3-27 18:48:56
http://reply.papertrans.cn/47/4648/464703/464703_36.png镇痛剂 发表于 2025-3-27 23:21:29
Economics of Inflammatory Bowel Disease,ver-changing world of medical economics, it is reasonable to consider the economic impact of these diseases and their therapies. Economic outcomes are increasingly being requested by many parties: insurers, hospitals, the government, physicians, and, of course, the patients.不来 发表于 2025-3-28 03:23:29
http://reply.papertrans.cn/47/4648/464703/464703_38.png欲望 发表于 2025-3-28 08:12:44
http://reply.papertrans.cn/47/4648/464703/464703_39.pngCUB 发表于 2025-3-28 11:42:07
Nutritional/Metabolic Issues in the Management of Inflammatory Bowel Disease,e role of nutritional support in the induction of a remission in the setting of a newly identified disease or an acute exacerbation; 2) the role of nutrition in the maintenance of long-term remission; 3) nutrition support for the treatment of IBD complications; and 4) management of nutritional deficits and metabolic complications secondary to IBD.